Corrigendum to "A glimpse into past, present, and future DNA sequencing" [Mol. Genet. Metab. 110 (2013) 3-24].
作者信息
Morey Marcos, Fernández-Marmiesse Ana, Castiñeiras Daisy, Fraga José M, Couce María L, Cocho José A
机构信息
Unidad de Diagnóstico y Tratamiento de Enfermedades Metabólicas Congénitas, Hospital Clínico Universitario de Santiago, A Choupana s/n, 15706 Santiago de Compostela, Spain.
Unidad de Diagnóstico y Tratamiento de Enfermedades Metabólicas Congénitas, Departamento de Pediatría, Hospital Clínico Universitario de Santiago, Universidad de Santiago de Compostela, A Choupana s/n, 15706 Santiago de Compostela, Spain.
出版信息
Mol Genet Metab. 2015 Mar;114(3):484. doi: 10.1016/j.ymgme.2015.01.009. Epub 2015 Feb 11.
PMID:25877474
Abstract
摘要
相似文献
1
Corrigendum to "A glimpse into past, present, and future DNA sequencing" [Mol. Genet. Metab. 110 (2013) 3-24].《“窥探DNA测序的过去、现在和未来”的勘误》[《分子遗传学与代谢》110(2013)3 - 24]
Mol Genet Metab. 2015 Mar;114(3):484. doi: 10.1016/j.ymgme.2015.01.009. Epub 2015 Feb 11.
2
Corrigendum to "Next generation sequencing of patients with mut methylmalonic aciduria: Validation of somatic cell studies and identification of 16 novel mutations." [Mol. Genet. Metab. (Aug 2016); 118(4): 264-71].《甲基丙二酸尿症患者的下一代测序：体细胞研究的验证及16个新突变的鉴定》勘误 [《分子遗传学与代谢》（2016年8月）；118(4): 264 - 71]
Mol Genet Metab. 2017 Mar;120(3):295. doi: 10.1016/j.ymgme.2016.11.001.
3
Corrigendum to "Risk factors for developing mineral bone disease in phenylketonuric patients" [Mol. Genet. Metab. 108 (2013) 149-154].《苯丙酮尿症患者发生矿物质骨病的危险因素》[《分子遗传学与代谢》108(2013)149 - 154]的勘误
Mol Genet Metab. 2015 Mar;114(3):483. doi: 10.1016/j.ymgme.2015.01.008. Epub 2015 Feb 11.
4
Corrigendum to "Tetrahydrobiopterin therapy vs phenylalanine-restricted diet: impact on growth in PKU" [Mol. Genet. Metab. 109 (2013) 331-338].《四氢生物蝶呤疗法与苯丙氨酸限制饮食：对苯丙酮尿症患者生长的影响》勘误 [《分子遗传学与代谢》109 (2013) 331 - 338]
Mol Genet Metab. 2015 Mar;114(3):485. doi: 10.1016/j.ymgme.2015.01.010. Epub 2015 Feb 12.
5
Corrigendum to "Clinical and metabolic findings in patients with methionine adenosyltransferase I/III deficiency detected by newborn screening" [Mol. Genet. Metab. 110 (2013) 218-221].《新生儿筛查检测出的蛋氨酸腺苷转移酶I/III缺乏症患者的临床和代谢发现》勘误 [《分子遗传学与代谢》110 (2013) 218 - 221]
Mol Genet Metab. 2015 Mar;114(3):486. doi: 10.1016/j.ymgme.2015.01.011. Epub 2015 Feb 11.
6
Corrigendum to "GJC2 promoter mutations causing Pelizaeus-Merzbacher-like disease" [Mol. Genet. Metab. 111 (2014) 393-398].《“导致佩利措伊斯-梅茨巴赫样病的GJC2启动子突变”的勘误》[《分子遗传学与代谢》111(2014)393 - 398]
Mol Genet Metab. 2016 Nov;119(3):293. doi: 10.1016/j.ymgme.2016.06.011.
7
Corrigendum to "In vitro evaluation of 2-hydroxyalkylated β-cyclodextrins as potential therapeutic agents for Niemann-pick type C disease" [Mol. Genet. Metab. (2016) 214-219].
Mol Genet Metab. 2017 Mar;120(3):296-297. doi: 10.1016/j.ymgme.2016.09.004. Epub 2016 Oct 10.
8
Corrigendum to "Development of hypomelanotic macules is associated with constitutive activated mTORC1 in tuberous sclerosis complex" [Mol. Genet. Metab. 120(4) (Apr 2017) 384-391].
Mol Genet Metab. 2018 Dec;125(4):361. doi: 10.1016/j.ymgme.2017.11.007. Epub 2018 Jan 8.
9
Corrigendum to "Pyridoxine-5'-phosphate oxidase (Pnpo) deficiency: Clinical and biochemical alterations associated with the C.347g>A (P.·Arg116gln) mutation" [Mol. Genet. Metab. 122/1-2 (2017) 135-142].
Mol Genet Metab. 2018 Dec;125(4):359. doi: 10.1016/j.ymgme.2018.02.017. Epub 2018 Mar 14.
10
Corrigendum to "A systematic cross-sectional survey of multiple sulfatase deficiency" [Mol Genet Metab. 2020 Aug;130(4):283-288].《多重硫酸酯酶缺乏症的系统横断面调查》的勘误 [《分子遗传学与代谢》。2020年8月；130(4):283 - 288]
Mol Genet Metab. 2020 Sep-Oct;131(1-2):284. doi: 10.1016/j.ymgme.2020.10.012. Epub 2020 Nov 2.
Zotero 插件